COMORBIDITIES WITH THE HIGH RISK OF DEATH AMONG COVID-19 PATIENTS: LEARNING FOR INDONESIA
Downloads
Background: In general, the entire population is vulnerable to COVID-19, but epidemiological research shows that the elderly and people with comorbid are more susceptible to COVID-19 and has a high risk of experiencing poor outcomes and death if infected with COVID-19. Purpose: This study aims to identify comorbidities with a high risk of death common among COVID-19 patients in China and the United States to provide learning for Indonesia in COVID-19 management. Methods: The literature review method was done by searching relevant articles through Google Scholar and ScienceDirect. Inclusion criteria are all original research and case series containing epidemiological information and comorbidities in COVID-19 patients aged >19 years with full text and open access. Exclusion criteria are study COVID-19 concerning children and adolescents (≤19 years) and study without comorbidities information. There is no language selection because all articles found are in English. Results: There are eight articles suitable for the criteria. Four articles were research conducted in China, and four articles were done in the United States. The articles use case series, cohort, and cross-sectional methods. Conclusion: Common comorbidities among COVID-19 patients are hypertension, diabetes, and cardiovascular disease in China and the United States. A more significant number of comorbidities also correlated with a higher risk of death.
Alkundi, A., Mahmoud, I., Musa, A., Naveed, S., & Alshawwaf, M. (2020). Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study. Diabetes Research and Clinical Practice, 165, 1–6. https://doi.org/10.1016/j.diabres.2020.108263
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020). Characteristics and outcomes of 21 critically ill patients with Covid-19 in Washington State. JAMA - Journal of the American Medical Association, 323(16), 1612–1614. https://doi.org/10.1093/cid/civ1020
Baradaran, A., Ebrahimzadeh, M. H., Baradaran, A., & Kachooei, A. R. (2020). Prevalence of comorbidities in Covid-19 patients: a systematic review and meta-analysis. Archives of Bone and Joint Surgery, 8(Suppl 1), 247–255. https://doi.org/10.22038/abjs.2020.47754.2346
Bialek, S., Boundy, E., Bowen, V., Chow, N., Cohn, A., Dowling, N., ... Sauber-Schatz, E. (2020). Severe outcomes among patients with coronavirus disease 2019 (Covid-19) ” United States, February 12–March 16, 2020. Morbidity and Mortality Weekly Report, 69(12), 343–346. https://doi.org/10.15585/mmwr.mm6912e2
Chow, N., Felming-Dutra, K., Gierke, R., Hall, A., Hughes, M., Pilishvili, T., ... Ussery, E. (2020). Preliminary estimates of the revalence of selected underlying health conditions among patients with Corona virus disease 2019 - United States, February 12-March 28, 2020. Morbidity and Mortality Weekly Report, 69(13), 382–386.
Du, R. H., Liang, L. R., Yang, C. Q., Wang, W., Cao, T. Z., Li, M., ... Shi, H. Z. (2020). Predictors of mortality for patients with COVID-19 pneumonia caused by SARSCoV- 2: a prospective cohort study. European Respiratory Journal, 55(5), 1–8. https://doi.org/10.1183/13993003.00524-2020
Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention. (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi, 41(2), 145–151. https://doi.org/10.3760/cma.j.issn.0254-6450.2020.02.003
Fried, M. W., Crawford, J. M., Mospan, A. R., Watkins, S. E., Munoz Hernandez, B., Zink, R. C., ... Brown, R. S. (2020). Patient characteristics and outcomes of 11,721 patients with Covid-19 hospitalized across the United States. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, ciaa1268. https://doi.org/10.1093/cid/ciaa1268
Guan, W., Liang, W., Zhao, Y., Liang, H., Chen, Z., Li, Y., ... He, J. (2020). Comorbidity and its impact on 1590 patients with Covid-19 in China: a nationwide analysis. European Respiratory Journal, 55, 1–14. https://doi.org/10.1183/13993003.00547-2020
Gupta, S., Hayek, S. S., Wang, W., Chan, L., Mathews, K. S., Melamed, M. L., ... Leaf, D. E. (2020). Factors associated with death in critically ill patients with coronavirus disease 2019 in the US. JAMA Internal Medicine, 02115(11), 1436–1446. https://doi.org/10.1001/jamainternmed.2020.3596
Imam, Z., Odish, F., Gill, I., O'Connor, D., Armstrong, J., Vanood, A., ... Halalau, A. (2020). Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States. Journal of Internal Medicine, 288(4), 469–476. https://doi.org/https://doi.org/10.1111/joim.13119
John Hopkins Coronavirus Resource Center. (2020). Mortality Analyses. John Hopkins University Medicine. USA. Retrieved October 4, 2020, from https://coronavirus.jhu.edu/data/mortality
Liu, K., Chen, Y., Lin, R., & Han, K. (2020). Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. Journal of Infection, 80(6), e14–e18. https://doi.org/10.1016/j.jinf.2020.03.005
Marcello, R. K., Dolle, J., Grami, S., Adule, R., Li, Z., Tatem, K., ... Davis, N. (2020). Characteristics and outcomes of COVID-19 patients in New York City's public hospital system. PLoS ONE, 15(12), 1–16. https://doi.org/10.1371/journal.pone.0243027
Ministry of Health RI. (2020). Current situation of the development of the novel coronavirus (Covid-19): data reported until 19 October 2020. Ministry of Health RI. Indonesia. Retrieved October, 10, 2020, from https://covid19.kemkes.go.id/download/Situasi_Terkini_050520.pdf
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., ... Zanos, T. P. (2020). Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with Covid-19 in the New York city area. JAMA - Journal of the American Medical Association, 323(20), 2052–2059. https://doi.org/10.1001/jama.2020.6775
Wang, B., Li, R., Lu, Z., & Huang, Y. (2020). Does comorbidity increase the risk of patients with COVID-19. Aging, 12(7), 6049–6057. https://dx.doi.org/10.18632/aging.103000
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., ... Peng, Z. (2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA - Journal of the American Medical Association, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
World Health Organization. (2020a). Coronavirus disease (Covid-19): data as received by WHO from national authorities, as of 11 October 2020, 10 am CEST. World Health Organization. Geneva. Retrieved November 4, 2020, from https://www.who.int/publications/m/item/weekly-epidemiological-update---12-october-2020
World Health Organization. (2020b). Rolling updates on coronavirus disease (COVID-19): updated 31 July 2020. World Health Organization. Geneva. Retrieved October 4, 2020, from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
Yu, C., Lei, Q., Li, W., Wang, X., Li, W., & Liu, W. (2020). Epidemiological and clinical characteristics of 1663 hospitalized patients infected with COVID-19 in Wuhan, China: a single-center experience. Journal of Infection and Public Health, 13(9), 1202–1209. https://doi.org/10.1016/j.jiph.2020.07.002
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., ... Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395, 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
